Medibeacon Inc (Medibeacon) is a medical technology company. The company offers real time kidney function monitoring solutions. It offers the renal function system that helps clinicians with the continuous monitoring of the kidney. Medibeacon also provides pipeline a portfolio of the light activated agents and preclinical applications for transdermal renal function measurement continuously. The company provides measured GFR for preclinical studies. It serves medical schools, academic centers, research institutes, and pharmaceutical companies. Medibeacon is headquartered in Saint Louis, Missouri, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MediBeacon Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- MediBeacon Inc Company Overview
- MediBeacon Inc Company Snapshot
- MediBeacon Inc Pipeline Products and Ongoing Clinical Trials Overview
- MediBeacon Inc - Pipeline Analysis Overview
- MediBeacon Inc - Key Facts
- MediBeacon Inc - Major Products and Services
- MediBeacon Inc Pipeline Products by Development Stage
- MediBeacon Inc Ongoing Clinical Trials by Trial Status
- MediBeacon Inc Pipeline Products Overview
- MB-102
- MB-102 Product Overview
- MB-102 Clinical Trial
- MB-112
- MB-112 Product Overview
- MB-202
- MB-202 Product Overview
- MB-212
- MB-212 Product Overview
- MB-301
- MB-301 Product Overview
- MB-404
- MB-404 Product Overview
- Transdermal GFR Monitor
- Transdermal GFR Monitor Product Overview
- MediBeacon Inc - Key Competitors
- MediBeacon Inc - Key Employees
- MediBeacon Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- MediBeacon Inc, Recent Developments
- Jan 30, 2025: MediBeacon Receives PMA Approval for Transdermal GFR Monitor
- Jan 20, 2025: FDA approves MediBeacon's TGFR system for kidney function assessment
- Nov 16, 2022: MediBeacon receives $10 million in amended agreements with Huadong Medicine to accelerate development of transdermal GFR measurement system
- Oct 22, 2018: FDA grants breakthrough device status for MediBeacon''s Transdermal GFR Measurement System
- May 06, 2017: MediBeacon presents gastrointestinal permeability research
- Mar 02, 2017: MediBeacon Completes Successful Clinical Study of Transdermal Glomerular Filtration Rate Monitor on Impaired Kidney Function Subjects
- Oct 18, 2016: Gates Foundation awards $1.1 million grant for MediBeacon collaboration with Washington University
- Aug 08, 2016: NIH grant to support research on MediBeacon Fluorescent Tracer agent use in Ocular Angiography
- Sep 02, 2015: MediBeacon featured on Fox 2 News, St. Louis
- Jun 04, 2014: WAshington university school of medicine, in collaboration with MEDIBEACON LLC, Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- MediBeacon Inc Pipeline Products and Ongoing Clinical Trials Overview
- MediBeacon Inc Pipeline Products by Equipment Type
- MediBeacon Inc Pipeline Products by Indication
- MediBeacon Inc Ongoing Clinical Trials by Trial Status
- MediBeacon Inc, Key Facts
- MediBeacon Inc, Major Products and Services
- MediBeacon Inc Number of Pipeline Products by Development Stage
- MediBeacon Inc Pipeline Products Summary by Development Stage
- MediBeacon Inc Ongoing Clinical Trials by Trial Status
- MediBeacon Inc Ongoing Clinical Trials Summary
- MB-102 - Product Status
- MB-102 - Product Description
- MB-102 - A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography As Compared to Fluorescein Sodium
- MB-112 - Product Status
- MB-112 - Product Description
- MB-202 - Product Status
- MB-202 - Product Description
- MB-212 - Product Status
- MB-212 - Product Description
- MB-301 - Product Status
- MB-301 - Product Description
- MB-404 - Product Status
- MB-404 - Product Description
- Transdermal GFR Monitor - Product Status
- Transdermal GFR Monitor - Product Description
- MediBeacon Inc, Key Employees
- MediBeacon Inc, Subsidiaries
- Glossary
- MediBeacon Inc Pipeline Products by Equipment Type
- MediBeacon Inc Pipeline Products by Development Stage
- MediBeacon Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fujifilm Holdings America Corp
- GE HealthCare Technologies Inc
- Philips Healthcare Informatics Inc
- Carestream Molecular Imaging
- Canon USA Inc
